367 related articles for article (PubMed ID: 8356789)
21. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.
Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL
Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266
[TBL] [Abstract][Full Text] [Related]
22. Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells.
Bird C; Burke J; Gleeson PA; McCluskey J
J Biol Chem; 1990 Nov; 265(31):19151-7. PubMed ID: 2229068
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
24. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
Schwartz S; Felber BK; Pavlakis GN
J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
[TBL] [Abstract][Full Text] [Related]
25. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
26. In silico mutagenesis of RNA splicing in HIV-1.
Kim H; Yin J
Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
[TBL] [Abstract][Full Text] [Related]
27. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
29. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
[TBL] [Abstract][Full Text] [Related]
30. The tat gene and protein of the human immunodeficiency virus type 1.
Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G
New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763
[No Abstract] [Full Text] [Related]
31. Tat is required for efficient HIV-1 reverse transcription.
Harrich D; Ulich C; García-Martínez LF; Gaynor RB
EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a nuclear retention sequence within the 3' region of the HIV-2 envelope gene.
Keller R; Montagnier L; Cordonnier A
Virology; 1993 Jan; 192(1):33-7. PubMed ID: 8517024
[TBL] [Abstract][Full Text] [Related]
33. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
Riggs NL; Little SJ; Richman DD; Guatelli JC
Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
[TBL] [Abstract][Full Text] [Related]
34. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
[TBL] [Abstract][Full Text] [Related]
35. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA.
Unger RE; Stout MW; Luciw PA
Virology; 1991 May; 182(1):177-85. PubMed ID: 2024463
[TBL] [Abstract][Full Text] [Related]
36. The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23.
Miyazaki Y; Takamatsu T; Nosaka T; Fujita S; Martin TE; Hatanaka M
Exp Cell Res; 1995 Jul; 219(1):93-101. PubMed ID: 7628555
[TBL] [Abstract][Full Text] [Related]
37. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
Derse D; Dorn P; DaSilva L; Martarano L
Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129
[TBL] [Abstract][Full Text] [Related]
38. Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.
Konopka K; Düzgüneş N; Rossi J; Lee NS
J Drug Target; 1998; 5(4):247-59. PubMed ID: 9713975
[TBL] [Abstract][Full Text] [Related]
39. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
Kim YS
Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
[TBL] [Abstract][Full Text] [Related]
40. The CAEV tat gene trans-activates the viral LTR and is necessary for efficient viral replication.
Saltarelli MJ; Schoborg R; Gdovin SL; Clements JE
Virology; 1993 Nov; 197(1):35-44. PubMed ID: 8212571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
